Immune response to SARS-CoV-2 mRNA booster vaccinations in relapsing multiple sclerosis patients treated with ofatumumab s.c.-Final results from the open-label multicenter KYRIOS trial

Authors
Category Primary study
ConferenceMSmilan2023
Year 2023
This article has no abstract
Epistemonikos ID: e66b3ad92d639c7c42d94dea3a8486f007f30485
First added on: Jan 07, 2026